<DOC>
	<DOCNO>NCT02632903</DOCNO>
	<brief_summary>This study explore effect zoledronic acid incident vertebral fracture osteonecrotic lesion child recently diagnose acute lymphoblastic leukemia .</brief_summary>
	<brief_title>Intravenous Zoledronic Acid Treatment Osteoporosis Osteonecrosis Children With Leukemia : A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteonecrosis</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>1 . Subject subject 's legally acceptable representative provide informed consent . 2 . Children age 8 16 year time enrolment confirm diagnosis acute lymphoblastic leukemia . 3 . Children painful vertebral fracture osteonecrotic lesion identify lateral spine radiograph ( vertebral fracture ) MRI ( osteonecrosis ) 8 12 week follow initiation chemotherapy . 1 . Any child treating physician feel participation advise . 2 . Prior treatment osteoporosis agent ( e.g . bisphosphonate ) . 3 . Comorbidities affect musculoskeletal health ( e.g . cerebral palsy ) . 4 . Children renal failure ( eGFR &lt; 60ml/min/1.73m2 ) . 5 . Children untreated vitamin D deficiency ( vitamin D &lt; 50nmol/L ) . 6 . Children hypocalcemia . 7 . Children plan dental procedure and/or dental surgery course study . 8 . Children asthma acetylsalicylic acid ( ASA ) sensitive . 9 . Children document history atrial fibrillation . 10 . Currently pregnant planning pregnancy study . 11 . Currently breastfeed plan breastfeeding study .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>